Clinical Trial Update: The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated whether Polymyxin B protects against sepsis-induced kidney dysfunction; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infection
• Sepsis

Drugs mentioned

• POLYMYXIN B (POLYMYXIN B SULFATE)

Snippet

Sponsor: University of Turin, Italy | Conditions: Gram-Negative Bacterial Infections, Sepsis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-04